FFRct vs TeraRecon Cardiovascular.Calcification.CT
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A (HeartFlow FFRct) provides a non-invasive functional assessment of coronary artery blood flow to aid in diagnosing coronary artery disease and guiding treatment strategies. Tool B (TeraRecon Cardiovascular.Calcification.CT) focuses on the automated detection and measurement of coronary artery calcifications for calcium scoring and broader anatomical analysis. While both utilize AI for cardiac CT analysis, Tool A offers physiological insights into blood flow restriction, whereas Tool B quantifies anatomical burden and risk.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
HeartFlow FFRct Analysis provides a non-invasive assessment of coronary artery blood flow and FFRct values to aid in diagnosing coronary artery disease and guiding treatment strategies. TeraRecon Cardiovascular.Calcification.CT automatically detects and measures calcifications in coronary arteries, outputting a mask for calcium scoring systems like Agatston, volume, and mean mass measurements.
HeartFlow FFRct Analysis has a CMS payment rate of $1,017 (2025), with commercial payer rates varying, and requires contacting the company for specific pricing. TeraRecon Cardiovascular.Calcification.CT is offered on a subscription-based model with a single annual fee, designed to provide operational budget flexibility.
HeartFlow FFRct Analysis utilizes AI and computational fluid dynamics (CFD) to create personalized 3D digital models of coronary arteries from CCTA scans and analyze blood flow. TeraRecon Cardiovascular.Calcification.CT employs AI-powered software to perform automatic 3D segmentation of calcified plaques in coronary arteries from CT images.
HeartFlow FFRct Analysis focuses on non-invasive diagnostic analysis of coronary arteries, providing FFRct values to assess blood flow and aid in treatment decisions. TeraRecon Cardiovascular.Calcification.CT is part of a broader CT Cardiac package that includes features like zero-click centerline creation, vessel segmentation and analysis (plaque, stenosis, curvature, tortuosity), cardiac structure segmentation, and functional analysis.
HeartFlow FFRct Analysis helps guide treatment strategies and revascularization decisions by integrating anatomical and physiological data from CCTA to identify areas of narrowing and assess blood flow. TeraRecon Cardiovascular.Calcification.CT provides calcium scoring (Agatston, volume, mean mass), which is used in conjunction with other patient information by trained professionals for patient management decisions.